(12 June 2008, Cambridge, UK) Linguamatics Ltd, a leader in enterprise
text mining for the life science and other markets, today announced that
it has joined the Microsoft BioIT Alliance, an association of life
science organizations and informatics companies whose focus is to
enhance collaboration and accelerate the pace of drug discovery and
development.
“As the amount of textual information impacting drug discovery and
development programs grows exponentially each year, the ability to
extract and share decision-relevant knowledge is crucial to streamline
the process and raise productivity,” said Roger Hale, COO and Co-founder
of Linguamatics. “Linguamatics is delighted to be part of Microsoft’s
BioIT Alliance. As a leader in knowledge discovery from text, we look
forward to working with other alliance members to explore new ways in
which the immense value of text mining can be exploited across complex,
multidisciplinary organizations like pharmaceutical companies.”
“We are very pleased to welcome Linguamatics to the BioIT Alliance,”
said Rudy Potenzone, Worldwide Industry Technology Strategist for
Pharmaceuticals at Microsoft and BioIT Alliance Coordinator. “Their
commitment to innovation coupled with world-class experience and
expertise in discovering and extracting relevant facts and relationships
from text across the enterprise complements the capabilities of other
Alliance members.”
The BioIT Alliance is designed to enable collaboration among
organizations in the life sciences field in order to shorten the time
between discovery of new biological data and the application of that
knowledge to human health.
NOTES TO EDITORS
ABOUT THE BIOIT ALLIANCE
Formed in 2006, the BioIT Alliance is a cross-industry group working to
integrate science and technology in order to accelerate the pace of drug
discovery and realize the potential of personalized medicine. Founding
members include Accelrys Software Inc., Affymetrix, Inc., Agilent
Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The
BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences
Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P.,
Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems
Inc., The Scripps Research Institute, VizX Labs LLC and other key
companies in the pharmaceutical, biotech, hardware and software
industries. Additional information about the BioIT Alliance can be found
on the BioIT Alliance Web site at
http://www.bioitalliance.org.
ABOUT LINGUAMATICS
Linguamatics helps organizations to maximize the value derived from
information resources through effective deployment of innovative natural
language processing (NLP) based technology. The versatile interactive
information extraction system, I2E, helps organizations to do much more
than simply cope with vast quantities of information. Its unique
combination of search and text mining helps organizations to turn this
information into a competitive advantage. From life sciences and
healthcare to business intelligence, from media analysis to security,
users mine large collections of documents, extracting relevant facts,
relationships and quantitative data from content such as scientific
papers, news feeds, patents, or internal reports. Linguamatics has a
rapidly growing user community with I2E deployed at most top-10 pharma
companies. The company was founded in 2001, and has headquarters in
Cambridge, UK.
For further information on Linguamatics products and solutions, visit
www.linguamatics.com.
The Linguamatics logo is a trademark of Linguamatics Ltd. All rights
reserved. All other trademarks mentioned in this document are the
property of their respective owners.
###
For further information, please contact:
Judith Bandy
Linguamatics
Tel: +44 (0)7912 944385
Email: judith.bandy@linguamatics.com
www.linguamatics.com